GlassScriptPhysician profile
Emily C Clements
NPI 1851502926
$1,589.52
in general payments reported to CMS, 2019-2025
23 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $202 · 2021: $398 · 2022: $319 · 2023: $94.56 · 2024: $249 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462 · Education: $53.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.57 |
| Education | $53.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.57 | 2019-2022 | |
| Hologic Sales and Service, LLC | $145.45 | 2019-2025 | Aptima |
| Baxter Healthcare | $140.35 | 2024-2025 | Seprafilm, Adept, Perclot |
| Pfizer INC. | $115.41 | 2020-2025 | |
| Therapeuticsmd, INC. | $112.95 | 2019-2022 | |
| Millicent US INC | $102.46 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $83.34 | 2021-2023 | |
| Exeltis, USA INC. | $80.77 | 2021-2025 | Slynd |
| Organon LLC | $77.45 | 2022-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $61.58 | 2019-2020 | |
| Myovant Sciences INC. | $50.00 | 2021-2022 | |
| Momentis Surgical INC. | $50.00 | 2022 | |
| Coopersurgical, INC. | $42.19 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $36.22 | 2021-2024 | Gardasil 9, Gardasil |
| Amgen INC. | $28.35 | 2019-2025 | Prolia, Evenity |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $26.85 | 2021-2023 | Balcoltra |
| Agile Therapeutics, INC. | $24.49 | 2021 | |
| Ascend Therapeutics US, LLC | $23.64 | 2022 | |
| Evofem Biosciences, INC. | $20.30 | 2021 | |
| Axonics, INC. | $17.11 | 2022 | |
| Laborie Medical Technologies Corp. | $16.83 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.21 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.